Notice of 36th Annual General Meeting including Annual Report for the FY 2024-25
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Zenotech Laboratories has sent out the notice for its 36th Annual General Meeting (AGM) scheduled for Friday, September 26, 2025 at 10:30 a.m. IST, to be held via Video Conferencing. The cut-off date for e-voting eligibility is September 19, 2025, with remote e-voting open from September 23 to September 25, 2025. Key items up for shareholder approval include adoption of FY25 audited financial statements, re-appointment of Mr. Rakeshchandra Jagdishprasad Sinha as a director, and appointment of M/s. G S K A & Co. as the new statutory auditor for a 5-year term (replacing PKF Sridhar & Santhanam LLP). Shareholders will also be asked to approve material related party transactions with promoter Sun Pharmaceutical Industries Limited worth up to ₹200 crores (covering conversion charges, purchases, equipment leasing, term loans, and reimbursements) between the 36th and 37th AGM. Additionally, Mr. Mahadev Tirunagari has been proposed as Secretarial Auditor for 5 years (April 2025 to March 2030) at ₹2 lakh per annum.
This is a routine AGM notice, but two items deserve attention. First, the ₹200 crore related-party transaction limit with Sun Pharma (Zenotech's holding company and main business partner under loan licensing) represents roughly 100% of Zenotech's annual turnover, highlighting how dependent the company is on its parent. Second, the auditor rotation from PKF Sridhar & Santhanam LLP to G S K A & Co. is a standard regulatory transition and is not expected to impact shareholders materially.